|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 July 2001, Vol. 98, No. 2, pp. 483-485
BRIEF REPORT
Acquired pure red cell aplasia associated with
lymphoproliferative disease of granular T lymphocytes
Ronald S. Go,
Chin-Yang Li,
Ayalew Tefferi, and
Robert L. Phyliky
From the Divisions of Hematology and Hematopathology,
Mayo Clinic and Foundation, Rochester, MN.
Acquired pure red cell aplasia (PRCA) can be associated with
lymphoproliferative disease of granular T lymphocytes (T-LDGL), also
known as T-cell large granular lymphocyte leukemia. Fifteen adult
patients with PRCA associated with T-LDGL comprise this study.
Neutropenia and rheumatoid arthritis were uncommon. All patients
responded to immunosuppressive therapy. The 2 most commonly used
treatments were prednisone and cyclophosphamide ± corticosteroids, producing overall response rates of 50% and 60%,
respectively. Treatment with cyclophosphamide was associated with a
more durable remission (median, 60 versus 7.5 months). After a median
follow-up of 67 months, 2 patients died of treatment-related
complications, one from myelodysplasia and another from
cyclosporine-induced renal failure. The clinical course and
treatment responses of PRCA associated with T-LDGL in this series were
similar to the general group of PRCA. Because T-LDGL is frequently
underdiagnosed, it is likely that a significant proportion of
idiopathic or primary PRCA is in fact secondary to T-LDGL.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K.-i. Sawada, M. Hirokawa, N. Fujishima, M. Teramura, M. Bessho, K. Dan, H. Tsurumi, S. Nakao, A. Urabe, M. Omine, et al.
Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group
Haematologica,
August 1, 2007;
92(8):
1021 - 1028.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Sokol and T. P. Loughran Jr.
Large granular lymphocyte leukemia.
Oncologist,
March 1, 2006;
11(3):
263 - 273.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Sloand, P. Scheinberg, J. Maciejewski, and N. S. Young
Brief Communication: Successful Treatment of Pure Red-Cell Aplasia with an Anti-Interleukin-2 Receptor Antibody (Daclizumab)
Ann Intern Med,
February 7, 2006;
144(3):
181 - 185.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Rose and N. Berliner
T-Cell Large Granular Lymphocyte Leukemia and Related Disorders
Oncologist,
June 1, 2004;
9(3):
247 - 258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. O'Keefe, M. Plasilova, M. Wlodarski, A. M. Risitano, A. R. Rodriguez, E. Howe, N. S. Young, E. Hsi, and J. P. Maciejewski
Molecular Analysis of TCR Clonotypes in LGL: A Clonal Model for Polyclonal Responses
J. Immunol.,
February 1, 2004;
172(3):
1960 - 1969.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
